BioAge Labs BIOA
NASDAQ BIOA
$7.09 -0.05 (-0.70%)
As of: Sep 30, 2026 · 12:20 PM EDT

BioAge Labs, Inc. (BIOA) EBT (2023 - 2026)

Updated

BioAge Labs' EBT came in at -$25.9 million for Q2 2026, compared with -$21.55 million a year earlier.

Analysis

BioAge Labs, Inc. (BIOA) EBT (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioAge Labs reported EBT of -$93.89 million; for FY2025, it was -$80.39 million.

  • Going back by year, EBT was -$70.93 million in FY2024 and -$53.76 million in FY2023.
  • The Q2 2026 figure represents the lowest quarterly EBT in data going back to Q3 2023.
  • Business Quant data shows BIOA's EBT at -$22.15 million (Q1 2026), -$25.72 million (Q4 2025) and -$20.13 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.90 Mn
Mar 31, 2026 -22.15 Mn
Dec 31, 2025 -25.72 Mn
Sep 30, 2025 -20.13 Mn
Jun 30, 2025 -21.55 Mn
Mar 31, 2025 -12.99 Mn
Dec 31, 2024 -21.59 Mn
Sep 30, 2024 -23.10 Mn
Jun 30, 2024 -13.51 Mn
Mar 31, 2024 -12.73 Mn
Dec 31, 2023 -15.78 Mn
Sep 30, 2023 -11.79 Mn
API Access

BioAge Labs, Inc. EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=BIOA&period=max&api_key=YOUR_API_KEY